Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00064987 · ClinicalTrials.gov registry record · Phase 2
Follicle Stimulating Hormone (FSH) to Improve Testicular Development in Men With Hypogonadism
A Phase 2 study, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- Terminated
- Registry status
- Phase 2
- Development phase
- 19
- Enrollment target
NCT00064987 is a Phase 2 study that was terminated before completion, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 19 participants.
The verdict
NCT00064987, a Phase 2 study, was terminated before completion, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 19 participants
- Enrollment target
Study Summary
Men with idiopathic hypogonadotropic hypogonadism (IHH, Kallmann Syndrome) may have small testicular size, low testosterone levels, no history of puberty, and infertility. These men lack a hormone called gonadotropin releasing hormone (GnRH) that stimulates the development and maturation of the testes. This study will investigate the impact of hormonal treatments on men with IHH. The goal of hormonal therapy is to maximize the potential fertility in these individuals.
Interventions
- PROCEDURE Testicular biopsy
- DRUG gonadotropin releasing hormone (GnRH)
- DRUG follicle stimulating hormone (FSH)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2001-04 |
| Est. Completion | 2012-10 |
| Phase | Phase 2 |
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)305 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00064987
The ClinicalTrials.gov registry entry for NCT00064987 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Testicular biopsy is the first listed.
NCT00064987 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00064987 about?
NCT00064987 is a clinical study titled "Follicle Stimulating Hormone (FSH) to Improve Testicular Development in Men With Hypogonadism". Men with idiopathic hypogonadotropic hypogonadism (IHH, Kallmann Syndrome) may have small testicular size, low testosterone levels, no history of puberty, and infertility. These men lack a hormone called gonadotropin releasing hormone (GnRH) that stimulates the development and maturation of the test...
What is the current status of trial NCT00064987?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 19 participants. The study started on 2001-04. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00064987?
The interventions under investigation include: Testicular biopsy (PROCEDURE), gonadotropin releasing hormone (GnRH) (DRUG), follicle stimulating hormone (FSH) (DRUG).
Who is sponsoring clinical trial NCT00064987?
This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.